07/02/2005
ReGen Therapeutics Plc (the ‘Company’) announces that on 7 February 2005 it received notification from New Opportunities Investment Trust Plc that, following a disposal by it of 1,000,000 ordinary shares of the Company, it now retains a holding of 10,712,121 ordinary shares representing 3.13% of the issued share capital of the Company.
For further information, please contact:
Andrew Marshall
Tel. 020 7960 6007
Marshall Robinson Roe